Upcoming IPOs this week: Mainboard segment stays quiet, 2 SME issues to open and 4 listings scheduled

Upcoming IPOs this week: The mainboard segment will remain muted this week as no new initial public offerings will open for subscription. However, the issues of RFBL Flexi Pack and Goldline Pharmaceutical will hit the primary market in the SME segment.

Listings that are scheduled to take place this week include Value 360 Communications, Recode Studios, Bagmane Prime Office REIT and Simca Advertising.

RFBL Flexi Pack IPO

The initial share sale of printed multi-layer flexible packaging material manufacturer RFBL Flexi Pack will be open for subscription from May 12 to May 14.

The issue is solely a fresh issuance of 70.65 lakh shares aggregating to ₹35.33 crore, according to the red herring prospectus (RHP).

The net proceeds from the issue will be utilised to meet capital expenditure requirements, funding working capital needs and general corporate purposes.

"We believe that the listing of equity shares will enhance our company's corporate image, brand name and create a public market for our equity shares in India," it said.

With a price band of ₹47 to ₹50 per share, a lot consists of 3,000 shares. The minimum investment for an individual investor is two lots or 6,000 shares.

RFBL Flexi Pack is into the manufacturing and trading of printed multilayer flexible packaging material such as plastic film rolls and pouches that are predominantly utilised for packaging applications across various industries. The company also deals in the trading of woven fabric packaging material and polyester laminated and other types of films.

Goldline Pharmaceutical IPO

The IPO of Goldline Pharmaceutical is entirely a fresh issuance of equity shares valued at ₹11.61 crore, with no offer for sale (OFS) component. The issue will be open from May 12 to May 14.

The money raised will be used for repayment of certain outstanding borrowings availed of by the company and corporate general purposes.

The price band has been set at ₹41 to ₹43 per share. A lot consists of 3,000 shares. The minimum investment for an individual investor is two lots of 6,000 shares.

Goldline Pharmaceuticals is involved in marketing pharmaceutical products under the brand name 'Goldline'.